We narrowed to 307 results for: GAI

...robust, specific, and can facilitate genome-scale gain-of-function screening when combined with a compact...

...fear of failure at all stages in the startup". To gain insight into "the random-walk" of a budding startup...

...in r/molecularbiology.   Oh, to be young again! Addgenie Marcy (now our Sr. Director of Production...

...you!)  Amount of information and level of detail Again, this is an obvious one on the surface, but it’s...

...mouse cortex. Image from He Tian. Congrats again to all the recipients! ...

...full-length protein that you want to generate antibodies against, or a unique peptide sequence derived from this...

...3-100 per cell, a stabilized promoter buffered against the effects of copy number on reporter gene expression...

... et al can be found here. Can’t find a RANbody against your favorite protein? No worries! As more nanobodies...

...anything good. And I will never write anything good again.’ ” For Susan, one of the most satisfying parts ...

... a kinases in a body part of choice. Zhou et al again used the Raf-MEK-ERK signaling pathway to demonstrate...

...constantly communicating with a tumor, proving once again that a tumor is always interacting with its surroundings...

...here at our new location to grow. We are hiring again and getting ready to embark on new exciting projects...

...from a complex mix using affinity chromatography against an amino acid sequence, or tag, on the protein....

...found (typically RNA that the RNAi is designed against), RISC can repress translation and/or degrade target...

...of “Gender, Science, and Technology” in 2011 and again in 2014. Resources on the Addgene Blog Learn How...

...enable you to quickly BLAST your sequencing result against the expected sequence for quick verification, which...

...tested T-DDOGs with two mouse GFP reporter lines; again, TdTomato was seen only in cells with GFP, at a ...

...from your membrane, allowing you to probe the blot again, almost like new. This approach preserves your sample...

... is not neutralized by pre-existing antibodies against AAV9-based vectors (and vice versa), enabling repeat...

...deschloroclozapine (DCZ) shows promise as a CNO alternative (Nagai et al., 2019). Regardless of which ligand you choose...